Eric Palmer

Eric Palmer is part of the Fierce Bioscience team and primary editor of FiercePharmaManufacturing.

[Eric Palmer @EricPFierce]

I will vouch for him as well and I’ve been in news business for 35 years. With the background in print, he has the skills to do whatever you need.

[Carly Helfand @CarlyHFierce]

If anyone needs a policy reporter, I can totally vouch for this one, given I watch him reporting all day from across our living room and all.

[Eric Palmer @EricPFierce]

It is not entirely accurate that the #FDA acted quickly. Two independent labs had established the dangers of #Zantac and #rantitine months ago but it equivocated until it did its own tests. Was it double-checking, or chagrined?
https://t.co/fBnjiO2EaZ

[Erin Fox @foxerinr]

Finally!!! Most places removed this from formulary and shelves months ago. Glad to see official action on this.

[Eric Palmer @EricPFierce]

@JoeBiden Given the times, a daily video briefing in which you bring together health experts who give real advice over COVID-19 would be useful. I would watch.

[Eric Palmer @EricPFierce]

@SamSifton Congrats on the new job. I really hope you’ll be able to keep up with the newsletter. The recipes are great but I most look forward to the “it doesn’t have anything to do with this or that…” portion of the NL. You have become my cultural shepherd.

[Eric Palmer @EricPFierce]

#Roche pleads for global harmony as it supercharges production of #Actemra #COVID19 tests
https://t.co/9m6RHj63iy

[Eric Palmer @EricPFierce]

@SamSifton Any new fly rods or reels among those new toys you mentioned?

[Eric Palmer @EricPFierce]

Recalls of specialized drugs like #Natpara create huge issues for patients.
https://t.co/JjU6AzbInW
#pharma #orphandrug

[Eric Palmer @EricPFierce]

#Takeda 's recall of eye drug #Natpara is going to be very tricky for both patients and the company. It is warning patients that simply stopping the drug is not an option.
https://t.co/mH1itq4NVd
#pharma

[Eric Palmer @EricPFierce]

Yes, #Novartis says, it is selling some of its manufacturing in #China.
https://t.co/gxAur1LDcg

[Eric Palmer @EricPFierce]

#Glenmark recalls creams that are either too wet or too gritty
https://t.co/hgk2NMf50x

They were produced in its Baddi plant, which has had warehouse heat issues in the past

FDA cites Glenmark plant where warehouse temperatures exceeded 110˚F
https://t.co/icBTMpyZp2

[Eric Palmer @EricPFierce]

Brian Kaspar says he didn't do anything wrong at #AveXis https://t.co/Scb6MuRNt6
So what really happened the #Novartis unit?
#genetherapy #Zolgensma Let us know.

[Eric Palmer @EricPFierce]

I suspect many of you have realized our sites are not currently accessible. Maybe yours are not as well. There is a regional outage at Cloudflare. Cloudflare says it's working on the issue.

[Eric Palmer @EricPFierce]

@FiercePharma This area of pharma manufacturing is getting very interesting.

[Eric Palmer @EricPFierce]

@SamSifton Happy Anniversary

[Eric Palmer @EricPFierce]

J&J reported $81.5 billion revenue in 2018, nearly as much as #AppleCard How did the reset of #pharma fare?
Take a look at The top 15 pharma companies by 2018 revenue
https://t.co/GgEgoPmShx

[Daniel Guinee @dpguinee]

I’ve made my picks #FierceMadness

[Eric Palmer @EricPFierce]

Last 'rights' for #Pfizer Hospira plant delivered in #FDA warning letter.
https://t.co/ESfeoAQ7UE

[Eric Palmer @EricPFierce]

Last 'rights' for #Pfizer Hospira plant delivered in #FDA warning letter.
https://t.co/ESfeoAyx36
#pharma

[Eric Palmer @EricPFierce]

Which #pharma manufacturer has the most to lose from patent expirations this year? Think of a Swiss drugmaker whose name begins with R and that faces an onslaught of #biosimilars https://t.co/he6inDhiQQ

[Eric Palmer @EricPFierce]

#FDA finds #Aurobindo sterile drug plant continues to have problems
https://t.co/FiyZxkBNE7
#pharma